ITGAX and lung cancer: Similarly, increased peptide‐presenting CD11c+ DC in draining lymph nodes (DLNs) 5 days after receiving 20 Gy was observed in lung cancer (A549)‐bearing mice, with increased intratumoral CD11c+TCR tetramer+ cells having an enhanced ability to stimulate T cells.